Fast Five Quiz: Management of Chronic Kidney Disease Anemia

Pradeep Arora, MD


April 19, 2022

Many patients with advanced CKD will develop anemia and impaired iron homeostasis, which are associated with adverse outcomes. Analyses have demonstrated that IV iron reduces the risk for myocardial infarction, stroke, and heart failure hospitalization in patients with CKD on dialysis, particularly at high doses. In addition, multiple studies have demonstrated that IV iron has resulted in a reduction of ESA dose.

Although IV iron administration is associated with an increased risk for infection and hypersensitivity reactions, it is the most effective method for increasing hemoglobin, ferritin, and transferrin saturation (TSAT), and reducing ESA use and blood transfusions.

Learn more about CKD anemia management.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.